Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KENT K LAM

Allopathic & Osteopathic Physicians Otolaryngology

NPI
1407176811
CMS profile
858458
Location
NORFOLK, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$23,600.85

73 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 2; records 51–73 of 73 matching records. This page contains 23 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KENT K LAM

NPI 1407176811 · CMS profile ID 858458

Allopathic & Osteopathic Physicians / Otolaryngology

NORFOLK, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–73 of 73 matching records. This page contains 23 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1407176811?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KENT K LAM, NPI 1407176811, CMS profile ID 858458. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–73 of 73 matching records. This page contains 23 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1407176811?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). KENT K LAM, NPI 1407176811, CMS profile ID 858458. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–73 of 73 matching records. This page contains 23 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1407176811?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
KENT K LAM, NPI 1407176811, CMS profile ID 858458, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–73 of 73 matching records. This page contains 23 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1407176811?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

73 matching records · $23,600.85 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 73 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–73 of 73.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Optinose US, Inc. $11.3704/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1163263678 CMS
Optinose US, Inc. $40.7504/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1163263680 CMS
Optinose US, Inc. $1,750.0004/29/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1163263682 CMS
Optinose US, Inc. $1,500.0004/08/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1163263702 CMS
GlaxoSmithKline, LLC. $56.8104/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190537769 CMS
GlaxoSmithKline, LLC. $41.7404/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190597798 CMS
GlaxoSmithKline, LLC. $72.3404/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191185158 CMS
GlaxoSmithKline, LLC. $61.8304/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191674402 CMS
AstraZeneca Pharmaceuticals LP $537.0004/04/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1207076629 CMS
GlaxoSmithKline, LLC. $205.8504/04/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1190358504 CMS
GlaxoSmithKline, LLC. $113.5204/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190554111 CMS
Optinose US, Inc. $24.6304/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1163263686 CMS
GENZYME CORPORATION $70.2904/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233522807 CMS
Optinose US, Inc. $100.2603/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1163263670 CMS
GlaxoSmithKline, LLC. $31.0202/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1190663927 CMS
GlaxoSmithKline, LLC. $424.0902/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1191287645 CMS
AERIN MEDICAL INC. $181.8402/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249132981 CMS
BIOPROTECT MEDICAL, INC. $30.5902/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252502432 CMS
GlaxoSmithKline, LLC. $99.9402/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190386784 CMS
Optinose US, Inc. $25.6901/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1163263660 CMS
Medtronic, Inc. $17.9101/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218867550 CMS
Medtronic, Inc. $131.3601/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218867552 CMS
Optinose US, Inc. $25.8001/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1163263656 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $39,736.67 90
PY2020 $10,556.19 47
PY2021 $14,590.69 55
PY2022 $18,871.15 59
PY2023 $10,512.14 21
PY2024 $9,167.38 20
PY2025 $23,600.85 73

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $3,490.58 13
PY2025 Principal investigator $16,128.00 1
PY2023 Recipient $3,395.03 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SANOFI US SERVICES INC. $16,128.00 10/14/2025 Non-covered Recipient Entity
Old Dominion University
A randomized, double-blind, placebo-controlled, parallel-group, 52-week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps No dispute reported 06/30/2026 1226087298
Recipient SANOFI US SERVICES INC. $93.56 06/17/2025 Covered Recipient Physician A randomized, double-blind, placebo-controlled, parallel-group, 52-week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps No dispute reported 06/30/2026 1226126837
Recipient SANOFI US SERVICES INC. $24.00 06/17/2025 Covered Recipient Physician A randomized, double-blind, placebo-controlled, parallel-group, 52-week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps No dispute reported 06/30/2026 1226126841
Recipient SANOFI US SERVICES INC. $16.80 06/17/2025 Covered Recipient Physician A randomized, double-blind, placebo-controlled, parallel-group, 52-week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps No dispute reported 06/30/2026 1226126845
Recipient SANOFI US SERVICES INC. $385.40 06/06/2025 Covered Recipient Physician A randomized, double-blind, placebo-controlled, parallel-group, 52-week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps No dispute reported 06/30/2026 1226126812
Recipient SANOFI US SERVICES INC. $458.57 06/06/2025 Covered Recipient Physician A randomized, double-blind, placebo-controlled, parallel-group, 52-week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps No dispute reported 06/30/2026 1226126816
Recipient SANOFI US SERVICES INC. $267.70 06/06/2025 Covered Recipient Physician A randomized, double-blind, placebo-controlled, parallel-group, 52-week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps No dispute reported 06/30/2026 1226126819
Recipient SANOFI US SERVICES INC. $50.00 06/06/2025 Covered Recipient Physician A randomized, double-blind, placebo-controlled, parallel-group, 52-week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps No dispute reported 06/30/2026 1226126824
Recipient SANOFI US SERVICES INC. $85.00 06/06/2025 Covered Recipient Physician A randomized, double-blind, placebo-controlled, parallel-group, 52-week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps No dispute reported 06/30/2026 1226126828
Recipient SANOFI US SERVICES INC. $69.81 06/06/2025 Covered Recipient Physician A randomized, double-blind, placebo-controlled, parallel-group, 52-week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps No dispute reported 06/30/2026 1226126832
Recipient SANOFI US SERVICES INC. $550.24 03/03/2025 Covered Recipient Physician A Randomized Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) No dispute reported 06/30/2026 1226126795
Recipient SANOFI US SERVICES INC. $678.23 03/03/2025 Covered Recipient Physician A Randomized Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) No dispute reported 06/30/2026 1226126800
Recipient SANOFI US SERVICES INC. $536.15 03/03/2025 Covered Recipient Physician A Randomized Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) No dispute reported 06/30/2026 1226126803
Recipient SANOFI US SERVICES INC. $275.12 03/03/2025 Covered Recipient Physician A Randomized Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) No dispute reported 06/30/2026 1226126808